Regenerative
-
Bi-axial bioreactor set to revolutionise pre-clinical trials in the field of regenerative medicine.
Technology jointly developed by National University of Singapore and Singapore Polytechnic, and commercialised by local start-up company.
Regenerative | 10 October 2011
-
Sigma-Aldrich Enters Distribution Agreement with Stemgent for Regenerative Medicine
Sigma-Aldrich has entered into an exclusive worldwide distribution agreement with Stemgent, the latter’s portfolio of lentivirus-based delivery systems for the generation of induced Pluripotent Stem (iPS) cells. The reprogramming technologie…
Regenerative | 17 December 2009
-
World Stem Cells and Regenerative Medicine Congress Asia
The World Stem Cells and Regenerative Medicine Congress Asia was held in Singapore in October 2009. Doug Sipp, Manager, Scientific Communication and International Affairs, Riken, Japan, discussed Asia’s performance in stem cell research. He said…
Regenerative | 23 November 2009
-
Regenerative Medicine Offers Hope for Incurable Diseases
Stem cell therapies could replace diseased body tissue, offering hope for patients with incurable conditions such as Parkinson’s disease and diabetes. At the 35th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT),…
Regenerative | 01 May 2009
